Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors

K El‐Adl, AGA El‐Helby, H Sakr… - Archiv der …, 2020 - Wiley Online Library
A novel series of 1‐benzylquinazoline‐2, 4 (1H, 3H)‐dione derivatives, 6a, b to 11a–e, was
designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT‐116 …
被引用次数：42 相关文章

Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2, 4 (1H, 3H)-dione bearing different moieties as VEGFR-2 inhibitors.

K El-Adl, AA El-Helby, H Sakr… - Archiv der Pharmazie, 2020 - europepmc.org
A novel series of 1-benzylquinazoline-2, 4 (1H, 3H)-dione derivatives, 6a, b to 11a-e, was
designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT-116 …

Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2, 4 (1H, 3H)-dione bearing different moieties as VEGFR-2 inhibitors

K El-Adl, AGA El-Helby, H Sakr… - Archiv der …, 2020 - pubmed.ncbi.nlm.nih.gov
A novel series of 1-benzylquinazoline-2, 4 (1H, 3H)-dione derivatives, 6a, b to 11a-e, was
designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT-116 …